University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
Cancer. 2010 Jan 15;116(2):476-85. doi: 10.1002/cncr.24774.
In 2006, it was estimated that 47 million people in the United States are without insurance. Studies have shown that patients who are uninsured or are insured by Medicaid are more likely to present with more advanced cancer. The objective of this study was to examine whether cancer recurrence and mortality of patients diagnosed with squamous cell carcinoma of the head and neck are associated with insurance status, after adjusting for known cancer risk factors. The main outcome measures were overall survival and relapse-free survival.
Retrospective cohort of patients with a biopsy-proven primary squamous cell carcinoma of the oral cavity, pharynx, or larynx diagnosed or treated at the University of Pittsburgh Medical Center between 1998 and 2007. Patients were stratified by their insurance status, including private insurance, uninsured/Medicaid, Medicare disability (Medicare under age 65), and Medicare 65 years + . Covariates included age, gender, race, smoking status, alcohol consumption, anatomic tumor site, treatment, stage at diagnosis, and occupational prestige score. Cox proportional hazards regression was used to estimate the effect of insurance status on overall survival, relapse-free survival, tumor stage, and lymph node involvement.
A total of 1231 patients were included in the analysis. Patients with Medicaid/uninsured (hazard ratio [HR], 1.50; 95% confidence interval [CI], 1.07-2.11) and Medicare disability (HR, 1.69; 95% CI, 1.16-2.48) had significantly lower overall survival compared with patients with private insurance; the result was independent of variables known to affect outcome, such as alcohol and tobacco use. For all squamous cell carcinoma of the head and neck (SCCHN) cancer sites, Medicaid and uninsured patients were significantly more likely to present with an advanced stage tumor at diagnosis (odds ratio [OR] = 2.94; 95% CI, 1.72-5.01) and to present with at least 1 positive lymph node (OR = 1.84; 95% CI, 1.16-2.90) compared with patients with private insurance.
Patients with Medicaid/uninsured and Medicare disability were at increased risk of death after a diagnosis of SCCHN when compared with patients with private insurance, after adjustment for age, gender, race, smoking, alcohol use, site, socioeconomic status, treatment, and cancer stage.
据估计,2006 年美国有 4700 万人没有医疗保险。研究表明,没有保险或由医疗补助计划承保的患者更有可能出现晚期癌症。本研究的目的是在调整已知癌症风险因素后,检查头颈部鳞状细胞癌患者的癌症复发和死亡率是否与保险状况有关。主要观察指标为总生存率和无复发生存率。
回顾性队列研究,纳入 1998 年至 2007 年在匹兹堡大学医学中心经活检证实的口腔、咽或喉原发性鳞状细胞癌患者。根据保险状况对患者进行分层,包括私人保险、无保险/医疗补助、医疗保险残疾(65 岁以下的医疗保险)和 65 岁以上的医疗保险。协变量包括年龄、性别、种族、吸烟状况、饮酒状况、解剖肿瘤部位、治疗、诊断时的分期和职业声望评分。采用 Cox 比例风险回归估计保险状况对总生存率、无复发生存率、肿瘤分期和淋巴结受累的影响。
共纳入 1231 例患者进行分析。与私人保险患者相比,医疗补助/无保险(风险比 [HR],1.50;95%置信区间 [CI],1.07-2.11)和医疗保险残疾(HR,1.69;95%CI,1.16-2.48)患者的总生存率显著降低;该结果独立于已知影响预后的变量,如酒精和烟草使用。对于所有头颈部鳞状细胞癌(SCCHN)癌症部位,医疗补助和无保险患者在诊断时更有可能出现晚期肿瘤(比值比 [OR] = 2.94;95%CI,1.72-5.01)和至少 1 个阳性淋巴结(OR = 1.84;95%CI,1.16-2.90),与私人保险患者相比。
与私人保险患者相比,调整年龄、性别、种族、吸烟、饮酒、部位、社会经济地位、治疗和癌症分期后,医疗补助/无保险和医疗保险残疾的患者在诊断为 SCCHN 后死亡的风险增加。